Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Afimoxifene Delivery in Radiated and Normal Breast
NCT04009044Phase 2Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Feb 2020
- Primary completion
- Jan 2026
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of afimoxifene in breast cancer, sponsored by Northwestern University. Started Feb 2020; status: active, not recruiting.
02
Drugs
afimoxifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04009044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04009044.